Adaptive Biotechnologies - PharmaKB

Company Reports

Company Reports

Disease Reports

Disease Reports

Company ReportsAdaptive Biotechnologies

Adaptive Biotechnologies(ADPT)

Download report

Favorite

Financial

Marketed Drugs

Clinical Trials

Financial

Stock price

*Currency in USD

Company Revenue

Quarterly

Quarterly

Annual

Annual

Projections

*Quarterly sales USD (in millions)

Plot placeholder

Mock data
Subscribe for the real data

Revenue by Drug

Marketed Drugs

No data

Clinical Trials

Therapeutic Areas:

All

Classification:

All

Approval:

All

Status:

All

Phases:

All

Drug Name

Phase 1

Phase 2

Phase 3

Phase 4

Indication

,

mantle-cell lymphoma

b-cell chronic lymphocytic leukemia

,

,

,

multiple myeloma

,

plasma cell neoplasms

,

non-hodgkin lymphoma

,

b-cell lymphoma

,

follicular lymphoma

,

,

large b-cell lymphoma diffuse

,

b-cell lymphoma marginal zone

,

prostatic neoplasms

,

castration-resistant prostatic neoplasms

,

hodgkin disease

,

myeloid sarcoma

,

non-small-cell lung carcinoma

,

,

t-cell lymphoma cutaneous

,

gata2 deficiency

,

pancreatic neoplasms

,

,

,

,

,

disease progression

,

male breast neoplasms

,

kidney diseases

,

renal insufficiency

,

retinal diseases

,

systemic lupus erythematosus

,

hemophagocytic lymphohistiocytosis

,

adenoid cystic carcinoma

,

triple negative breast neoplasms

,

,

idiopathic pulmonary fibrosis

,

pulmonary fibrosis

,

myelomonocytic leukemia chronic

,

myelomonocytic leukemia juvenile

,

hematologic neoplasms

,

follicular lymphoma

,

myeloproliferative disorders

,

precursor t-cell lymphoblastic leukemia-lymphoma

,

bcr-abl positive chronic myelogenous leukemia

,

b-cell lymphoma marginal zone

,

myelomonocytic leukemia acute

,

residual neoplasm

,

philadelphia chromosome

,

hematopoietic stem cell transplantation

,

reactive arthritis

,

,

breast neoplasms

,

waldenstrom macroglobulinemia

,

myelodysplastic-myeloproliferative diseases

,

t-cell lymphoma

,

t-cell lymphoma peripheral

,

neoplasm metastasis

,

,

burkitt lymphoma

,

immunoglobulin light-chain amyloidosis

,

primary myelofibrosis

,

,

healthy volunteers/patients

,

myeloid leukemia chronic-phase

,

small cell lung carcinoma

,

refractory anemia with excess of blasts

,

monocytic leukemia acute

,

precursor b-cell lymphoblastic leukemia-lymphoma

,

leukemia myeloid chronic atypical bcr-abl negative

,

myeloid leukemia accelerated phase

,

,

eyelid neoplasms

,

,

colorectal neoplasms

,

prolymphocytic leukemia

,

prolymphocytic leukemia t-cell

,

salvage therapy

,

erythroblastic leukemia acute

,

hypersensitivity

,

hematologic diseases

,

essential thrombocythemia

,

polycythemia vera

,

neutrophilic leukemia chronic

,

hypereosinophilic syndrome

,

,

large-cell lymphoma anaplastic

,

t-cell leukemia

,

respiratory aspiration

,

,

,

,

pneumococcal pneumonia

,

hairy cell leukemia

,

,

,

myelodysplastic syndromes

,

,

precursor cell lymphoblastic leukemia-lymphoma

,

non-hodgkin lymphoma

,

,

,

,

mantle-cell lymphoma

,

large b-cell lymphoma diffuse

,

b-cell lymphoma

,

multiple myeloma

,

plasma cell neoplasms

,

,

biphenotypic leukemia acute

,

promyelocytic leukemia acute

,

bone marrow transplantation

,

,

,

,

myeloid leukemia acute

,

myeloid leukemia

,

lymphoid leukemia

,

b-cell chronic lymphocytic leukemia

,

,

,

plasma cell leukemia

,

congenital abnormalities

,

eye abnormalities

,

chromosome aberrations

,

chromosome disorders

,

cardiac arrhythmias

,

sudden death cardiac

,

© 2020-2024 Collaborative Drug Discovery Inc. (CDD) | Terms of Use